EP 4255441 A1 20231011 - PRODRUG OF 5a-HYDROXY-6ß-[2-(1H-IMIDAZOL-4-YL)ETHYLAMINO]CHOLESTAN-3ß-OL AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAME FOR USE IN THE TREATMENT OF CANCER

Title (en)

PRODRUG OF 5a-HYDROXY-6ß-[2-(1H-IMIDAZOL-4-YL)ETHYLAMINO]CHOLESTAN-3ß-OL AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAME FOR USE IN THE TREATMENT OF CANCER

Title (de)

PRODRUG VON 5A-HYDROXY-6SS-[2-(1H-IMIDAZOL-4-YL)ETHYLAMINO!CHOLESTAN-3SS-OL UND PHARMAZEUTISCHE ZUSAMMENSETZUNGEN DAMIT ZUR VERWENDUNG BEI DER BEHANDLUNG VON KREBS

Title (fr)

PRODROGUE DU 5a-HYDROXY-6ß-[2-(1H-IMIDAZOL-4-YL)ETHYLAMINO]CHOLESTAN-3ß-OL ET COMPOSITIONS PHARMACEUTIQUES LE COMPRENANT POUR UTILISATION DANS LE TRAITEMENT DU CANCER

Publication

EP 4255441 A1 20231011 (FR)

Application

EP 21819893 A 20211203

Priority

BE 202005878 A 20201203
EP 2021084191 W 20211203

Abstract (en)

[origin: WO2022117824A1] The invention relates to a new compound of general formula (I), and/or a pharmaceutically acceptable salt of such a compound, and a pharmaceutical composition comprising at least said compound for use as a drug for shrinking cancerous tumours in mammals.

IPC 8 full level

A61K 31/575 (2006.01); A61K 31/58 (2006.01); A61K 31/704 (2006.01); A61K 33/24 (2019.01); A61K 33/36 (2006.01); A61K 45/06 (2006.01); A61P 35/00 (2006.01); A61P 35/02 (2006.01)

CPC (source: EP KR US)

A61K 31/575 (2013.01 - EP); A61K 31/58 (2013.01 - EP KR); A61K 31/704 (2013.01 - EP); A61K 33/24 (2013.01 - EP); A61K 33/36 (2013.01 - EP); A61K 45/06 (2013.01 - EP KR US); A61P 35/00 (2018.01 - EP KR US); A61P 35/02 (2018.01 - EP KR); C07J 43/003 (2013.01 - KR US); A61K 2300/00 (2013.01 - KR)

C-Set (source: EP)

Designated contracting state (EPC)

AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

Designated extension state (EPC)

BA ME

Designated validation state (EPC)

KH MA MD TN

DOCDB simple family (publication)

WO 2022117824 A1 20220609; AU 2021391628 A1 20230629; AU 2021391628 A9 20240912; BE 1028852 A1 20220628; BE 1028852 B1 20220705; CA 3200327 A1 20220609; CN 116546988 A 20230804; CN 116615202 A 20230818; EP 4255441 A1 20231011; JP 2024503572 A 20240126; KR 20230114274 A 20230801; US 2024002429 A1 20240104

DOCDB simple family (application)

EP 2021084191 W 20211203; AU 2021391628 A 20211203; BE 202005878 A 20201203; CA 3200327 A 20211203; CN 202180074458 A 20211028; CN 202180081946 A 20211203; EP 21819893 A 20211203; JP 2023533809 A 20211203; KR 20237021722 A 20211203; US 202118265186 A 20211203